Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Antoni Martínez-Rubio

Key Recent Advances in Atherosclerosis Treatment With Modern Lipid-Lowering Drugs: The New Frontier With PCSK9 Inhibitors

European Cardiology Review

Cardiovascular Medicine

English

Secondary Prevention in Patients With Non Valvular Atrial Fibrillation and Previous Stroke. Is It Possible to Have an Appropriate INR Control?

European Cardiology Review

Cardiovascular Medicine

English

Related publications

Adherence to Lipid Lowering Drugs in Patients With Schizophrenia

Clinical Therapeutics

English

Lipid Lowering Therapy and Circulating PCSK9 Concentration

Journal of Atherosclerosis and Thrombosis

Internal Medicine

Cardiovascular Medicine

English

Recent Advances in PDE4 Inhibitors as Immunoregulators and Antiinflammatory Drugs

English

Disadvantages of Current LDL-cholesterol Lowering and the Role of PCSK9 Inhibitors.

Cardiologia Croatica

Cardiovascular Medicine

English

Lipid-Lowering Drugs (Statins) and Peripheral Neuropathy

Electronic Physician

English

Recent Advances in Understanding Endothelial Dysfunction in Atherosclerosis

Clinical Medicine and Research

English

Successful Treatment of a Patient With Refractory Nephrotic Syndrome With PCSK9 Inhibitors: A Case Report

English

Development of Novel DNA-Encoded PCSK9 Monoclonal Antibodies as Lipid-Lowering Therapeutics

Molecular Therapy

Molecular Medicine

Molecular Biology

English

PCSK9 Inhibitor Improves Cardiac Function and Reduces Infarct Size in Rats With Ischaemia/Reperfusion Injury: Benefits Beyond Lipid‐lowering Effects

Journal of Cellular and Molecular Medicine

Molecular Medicine

English